August 22, 2008
Hatch Medical Signs Brokerage Agreement With Evexar Medical
US-based Hatch Medical, a medical device incubator and technology brokerage firm, has signed an agreement with the UK-based Evexar Medical to broker its collagen-based sealing technology, EndoSeal.
Evexar Medical, in co-operation with University College London, has developed a technology to address endoleaks. The patented Evexar EndoSeal technology effectively seals gaps that can occur between an endograft and an irregular vessel wall, ensuring a secure seal and substantially reducing the possibility of endoleaks, according to Hatch Medical.